Application of Citrate Dialysate in Chronic Haemodialysis
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 120
Summary
- Conditions
- Chronic Renal Disease
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
It is hypothesized that citrate dialysate may provide a local anticoagulation effect in the dialyser improving removal of uremic toxins. Study investigating the safety and efficacy of the citrate dialysis solution compared to standard acetate dialysis solution. Use of citrate dialysis solution is no...
It is hypothesized that citrate dialysate may provide a local anticoagulation effect in the dialyser improving removal of uremic toxins. Study investigating the safety and efficacy of the citrate dialysis solution compared to standard acetate dialysis solution. Use of citrate dialysis solution is not associated with a clinically relevant development of adverse events.
Tracking Information
- NCT #
- NCT01532297
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Michael Schmitz, Dr. Städt. Klinikum Solingen gemeinnützige GmbH Klinik für Nephrologie und Allgemeine Innere Medizin Principal Investigator: Olaf Loke, Dr. Nephrologische Gemeinschaftspraxis Principal Investigator: Klaus Kalb, Dr. Märkische Dialysezentren GmbH Principal Investigator: Bernhard Fach, Dr. PHV Dialysezentrum
Get Well Soon